Literature DB >> 18782312

Transitional cell carcinomas of the renal pelvis and the ureter: comparative demographic characteristics, pathological grade and stage and 5-year survival in a Taiwanese population.

Lia-Beng Tan1, Lin-Li Chang, Kuang-I Cheng, Chun-Hsiung Huang, Aij-Lie Kwan.   

Abstract

OBJECTIVE: To compare the predictive value for 5-year survival of demographic characteristics, pathological grade and stage between upper tract urothelial carcinoma (UTUC) of the renal pelvis (RPUC) and ureter (UUC) in a Taiwanese population. PATIENTS AND METHODS: In this study (1986-98) we analysed 141 patients with UTUC, including 71 with RPUC and 70 with UUC (median age 59 years; median follow-up 54 months, SD 2.5). Prognostic indicators were examined by univariate and multivariate logistic regression analyses.
RESULTS: A significant percentage of patients had tumour on the right side and a high proportion of those with UUC were women. Gross haematuria and hypertension were the most common symptoms of RPUC. The sensitivity of intravenous pyelography in diagnosing RPUC and UUC was 49% (34/69) and 36% (25/70), respectively. However, in patients assessed by retrograde pyelography the diagnostic sensitivity was 85% (60/71) for RPUC and 89% (55/62) for UUC. The incidence of tumour recurrence after nephroureterectomy with bladder cuff excision was significantly higher in those with UUC (13%) than RPUC (3.6%). Distant metastasis was detected in 37 of 141 (26%) patients, the most common sites being bone (46%), lung (22%), liver (14%) and colon (8%). Univariate logistic regression analysis showed significant differences in the prognosis for high-grade and high-stage tumours. The prognosis was particularly poor in patients aged >60 years. According to the multivariate logistic regression analysis, tumour stage and grade were the best outcome predictors for RPUC, but stage and age were the best outcome predictors for UUC.
CONCLUSION: UUC is more common in women and has a more aggressive clinical outcome than RPUC after nephroureterectomy with bladder cuff incision. Tumour stage and grade are the best predictors of survival in patients with RPUC. Also, in patients with UUC the prognosis is poor in older patients and those with advanced stages of cancer.

Entities:  

Mesh:

Year:  2008        PMID: 18782312     DOI: 10.1111/j.1464-410X.2008.07985.x

Source DB:  PubMed          Journal:  BJU Int        ISSN: 1464-4096            Impact factor:   5.588


  8 in total

1.  Upper urinary tract urothelial carcinoma: what have we learned in the last 4 years?

Authors:  Mesut Remzi; Shahrokh Shariat; Wilhelm Huebner; Harun Fajkovic; Christian Seitz
Journal:  Ther Adv Urol       Date:  2011-04

2.  Radiotherapy may improve overall survival of patients with T3/T4 transitional cell carcinoma of the renal pelvis or ureter and delay bladder tumour relapse.

Authors:  Bing Chen; Zhao-Chong Zeng; Guo-Min Wang; Li Zhang; Zong-Ming Lin; Li-An Sun; Tong-Yu Zhu; Li-Li Wu; Jian-Ying Zhang; Yuan Ji
Journal:  BMC Cancer       Date:  2011-07-14       Impact factor: 4.430

3.  Methylomics analysis identifies ZNF671 as an epigenetically repressed novel tumor suppressor and a potential non-invasive biomarker for the detection of urothelial carcinoma.

Authors:  Chia-Ming Yeh; Pi-Che Chen; Hsiao-Yen Hsieh; Yeong-Chin Jou; Chang-Te Lin; Ming-Hsuan Tsai; Wen-Yu Huang; Yi-Ting Wang; Ru-Inn Lin; Szu-Shan Chen; Chun-Liang Tung; Shu-Fen Wu; D Ching Chang; Cheng-Huang Shen; Cheng-Da Hsu; Michael W Y Chan
Journal:  Oncotarget       Date:  2015-10-06

4.  Risk Stratification of Upper Urinary Tract Urothelial Carcinoma Patients for Survival Prediction: A Simple Summation Scoring Method.

Authors:  Li-Jen Wang; Wen-Chi Chou; See-Tong Pang; Chih-Wei Yang; Cheng-Keng Chuang; Ying-Hsu Chang; Ming-Li Hsieh; Yon-Cheong Wong
Journal:  J Cancer       Date:  2018-06-06       Impact factor: 4.207

5.  Pre-therapy CT scan showing peritoneal thickening from metastatic renal pelvis carcinoma patients.

Authors:  Tzu-Yao Liao; Chuang-Chi Liaw; Ke-Hung Tsui; Yu-Hsiang Juan
Journal:  Med Oncol       Date:  2018-08-16       Impact factor: 3.064

6.  Comparison of oncological and perioperative outcomes of open, laparoscopic, and robotic nephroureterectomy approaches in patients with non-metastatic upper-tract urothelial carcinoma.

Authors:  Hakmin Lee; Hak Ju Kim; Sang Eun Lee; Sung Kyu Hong; Seok-Soo Byun
Journal:  PLoS One       Date:  2019-01-08       Impact factor: 3.240

7.  c-Myc Acts as a Competing Endogenous RNA to Sponge miR-34a, in the Upregulation of CD44, in Urothelial Carcinoma.

Authors:  Pie-Che Chen; Chih-Chia Yu; Wen-Yu Huang; Wan-Hong Huang; Yu-Ming Chuang; Ru-Inn Lin; Jora M J Lin; Hon-Yi Lin; Yeong-Chin Jou; Cheng-Huang Shen; Michael W Y Chan
Journal:  Cancers (Basel)       Date:  2019-09-28       Impact factor: 6.639

8.  Development and Validation of a Predictive Model to Evaluate the Risk of Bone Metastasis in Kidney Cancer.

Authors:  Shengtao Dong; Hua Yang; Zhi-Ri Tang; Yuqi Ke; Haosheng Wang; Wenle Li; Kang Tian
Journal:  Front Oncol       Date:  2021-11-25       Impact factor: 6.244

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.